Establishment of lung cancer patient-derived xenograft models and primary cell lines for lung cancer study
Abstract Background The overall 5-year survival rate of lung cancer is about 15% even with therapeutic drugs like tyrosine kinase inhibitors. Ideal models are urgently needed for exploring mechanisms and finding new drugs. Patient-derived xenografts (PDX) models and primary cells are both used to sc...
Main Authors: | Yanan Jiang, Jimin Zhao, Yi Zhang, Ke Li, Tiepeng Li, Xinhuan Chen, Simin Zhao, Song Zhao, Kangdong Liu, Ziming Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-018-1516-5 |
Similar Items
-
Advances in Patient Derived Tumor Xenograft (PDTX) Model from Lung Cancer
by: Baodong QIN, et al.
Published: (2017-10-01) -
Patient-derived non-small cell lung cancer xenograft mirrors complex tumor heterogeneity
by: Xuanming Chen, et al.
Published: (2021-02-01) -
Establishing and Maintaining an Extensive Library of Patient-Derived Xenograft Models
by: Marissa Mattar, et al.
Published: (2018-02-01) -
Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer
by: Xingxiang Pu, et al.
Published: (2018-11-01) -
Validity of patient-derived xenograft mouse models for lung cancer based on exome sequencing data
by: Jaewon Kim, et al.
Published: (2020-03-01)